Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bio-Rad Laboratories, Inc.

BIO ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: HOLD

Last Close

$378.00

▲ +2.56%

Market Cap $0.00 · Vol 109.54K

Key Metrics

P/E Ratio

45.82

FWD: 37.47

Market Cap

$0.00

Large Cap

Div Yield

N/A

EPS Growth

-2.81%

YoY

RSI (14)

37.68

Momentum

Beta

1.07

vs Market

52W High

$395.72

4.48% below

52W Low

$239.00

58.16% above

Volume

109.54K

Avg 73.48K

P/B

1.10

Price-to-book

ROE

3.86%

Return on equity

Free Float

83.46%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bio-Rad Laboratories, Inc. (BIO) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BIO pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.56%

+6.10%

+30.67%

+43.84%

YTD

+24.76%

+34.90%

+0.47%

-52.16%

Financials & Valuation

TTM · Annual

Total Revenue	$2.58B
Net Income	$759.90M
Revenue Growth (YoY)	-0.09%
Gross Margin	52.01%
Operating Margin	10.25%
Net Profit Margin	29.42%
ROE	3.86%
ROA · ROIC	9.98% · 9.71%

P/E Ratio	45.82
Forward P/E (FY1)	37.47
PEG Ratio	0.08
P/S	3.20
P/B	1.10
P/FCF	22.07
EPS Growth	-2.81%
Outstanding Shares	26.74M

Technical Indicators

50-Day SMA	$345.46
200-Day SMA	$303.77
RSI (14)	37.68
Beta	1.07
52-Week High	$395.72
52-Week Low	$239.00

Volume Today	109.54K
Avg Daily Volume (30D)	73.48K
Relative Volume	1.49x
Volatility (10D)	22.32
Volatility (30D)	25.79
Free Float	83.46%

Analyst Consensus

HOLD

Current Price $378.00

Mean Target $340.00

52W Low$239.00 52W High$395.72

Current

Target

$239.00 $395.72

Current Analyst target

-10.05% downside risk · 6 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S625W4

ISINUS0905722072

CountryUSA

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateOct 27, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

AORT Artivion, Inc. +1.64% AVTR Avantor, Inc. +1.85% ACU Acme United Corp +1.02% BDX Becton Dickinson and Co +1.65% APT Alpha Pro Tech Ltd +1.73%

Company Profile

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.